247 related articles for article (PubMed ID: 16723861)
1. Pulse pressure reduction and cardiovascular protection.
Laurent S; Tropeano AI; Boutouyrie P
J Hypertens Suppl; 2006 May; 24(3):S13-8. PubMed ID: 16723861
[TBL] [Abstract][Full Text] [Related]
2. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
Gosse P
Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
[TBL] [Abstract][Full Text] [Related]
3. Hypertension: which aspects of hypertension should we impact on and how?
Zanchetti A; Waeber B
J Hypertens Suppl; 2006 Aug; 24(5):S2-5. PubMed ID: 16936532
[TBL] [Abstract][Full Text] [Related]
4. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
5. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
Waeber B
J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence.
Chalmers J; Joshi R; Kengne AP; Ninomiya T; Bi Y; Bompoint S; Billot L; Patel A;
J Hypertens Suppl; 2008 Sep; 26(3):S21-7. PubMed ID: 19363849
[TBL] [Abstract][Full Text] [Related]
7. Renal protection in diabetic patients: benefits of a first-line combination of perindopril-indapamide (Preterax).
Ruilope LM; Segura J
J Hypertens Suppl; 2006 May; 24(3):S9-12. PubMed ID: 16723864
[TBL] [Abstract][Full Text] [Related]
8. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
Waeber B; de la Sierra A; Ruilope LM
Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
Holzgreve H; Risler T; Trenkwalder P
Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
[TBL] [Abstract][Full Text] [Related]
10. Advances in reducing the burden of vascular disease in type 2 diabetes.
Chalmers J; Joshi R; Patel A
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):434-7. PubMed ID: 18307736
[TBL] [Abstract][Full Text] [Related]
11. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
[TBL] [Abstract][Full Text] [Related]
12. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
Nilsson PM
Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
[No Abstract] [Full Text] [Related]
13. Implications of the ADVANCE study for clinical practice.
Zannad F
J Hypertens Suppl; 2008 Sep; 26(3):S29-32. PubMed ID: 19363850
[TBL] [Abstract][Full Text] [Related]
14. [ADVANCE: a morbidity mortality study of diabetes and hypertension].
Heim A; Feihl F; Waeber B
Rev Med Suisse; 2008 Jan; 4(139):28, 30, 32-3. PubMed ID: 18251212
[TBL] [Abstract][Full Text] [Related]
15. [Vascular impact of anti-hypertensive treatment and renal protection].
Mogensen CE
Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649
[TBL] [Abstract][Full Text] [Related]
16. Perindopril for the treatment of hypertension.
Ghiadoni L
Expert Opin Pharmacother; 2011 Jul; 12(10):1633-42. PubMed ID: 21599567
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.
Asmar RG; London GM; O'Rourke ME; Mallion JM; Romero R; Rahn KH; Trimarco B; Fitzgerald D; Hedner T; Duprez D; De Leeuw PW; Sever P; Battegay E; Hitzenberger G; de Luca N; Polónia P; Bénétos A; Chastang C; Ollivier JP; Safar ME;
J Hypertens Suppl; 2001 Nov; 19(4):S15-20. PubMed ID: 11848258
[TBL] [Abstract][Full Text] [Related]
18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of therapeutic strategies in the management of hypertension].
Waeber B
Curr Med Res Opin; 2005; 21 Suppl 5():S13-6. PubMed ID: 16197647
[TBL] [Abstract][Full Text] [Related]
20. You should treat patients over the age of 80 who have hypertension.
Lundberg GD
Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
[No Abstract] [Full Text] [Related]
[Next] [New Search]